Article Details

Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of ...

Retrieved on: 2022-10-17 11:13:02

Tags for this article:

Click the tags to see associated articles and topics

Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of .... View article details on hiswai:

Excerpt

LONDON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up